Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial
Verma S, Bhatt DL, Bain SC, et al.
Circulation 2018;137:2179-83
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Verma S, Bhatt DL, Bain SC, et al.
Circulation 2018;137:2179-83
Leggi
Sharma A, Cannon CP, White WB, et al.
J Am Heart Assoc. Pub. online May 16, 2018
Leggi
Candler TP, Mahmoud O, Lynn RM, Majbar AA, et al.
Diabet Med 2018;35(6):737-44
Leggi
Lablanche S, Vantyghem MC, Kessler L, et al.
Lancet Diabetes Endocrinol. Pub. online 15 May 2018
Leggi
Gallo M, Ruggeri RM, Muscogiuri G, et al; NIKE Group
Cancer Treat Rev 2018;67:1-9
Leggi
Lu L, Bennett DA, Millwood IY, et al.
PLoS Med 2018;15(5):e1002566.
Leggi
Gnatiuc L, Herrington WG, Halsey J, et al.
Lancet Diabetes Endocrinol. Pub. online 8 May 2018
Leggi
Norhammar A
Lancet Diabetes Endocrinol. Pub. online 5 May 2018
Leggi
Sortsø C, Komkova A, Sandbækn A, et al.
Diabetologia 2018;61:1306-14
Leggi
Hjort E, Ahlqvist E, Carlsson PO, et al.
Diabetologia 2018;61:1333-43
Leggi